Safety and Potential Therapeutic Effect of Two Intracavernous Autologous Bone Marrow Derived Mesenchymal Stem Cells injections in Diabetic Patients with Erectile Dysfunction: An Open Label Phase I Clinical Trial
Saddam Al Demour(University of Jordan), Abdalla Awidi(University of Jordan), Sofia Adwan(University of Jordan), Hussam Alhawari(University of Jordan), Adel Alrabadi(University of Jordan), Ahmad Jaradat(University of Jordan), Hanan Jafar(University of Jordan), Abedallatif AlSharif(University of Jordan), Ayman A. Zayed(Jordan Hospital)
Cited by 109
Related Papers
siRNA: Mechanism of action, challenges, and therapeutic approaches
|European Journal of Pharmacology|2021|428
Intra-articular injection of expanded autologous bone marrow mesenchymal cells in moderate and severe knee osteoarthritis is safe: a phase I/II study
|Journal of Orthopaedic Surgery and Research|2017|141
Mesenchymal stem cells and conditioned media in the treatment of multiple sclerosis patients: Clinical, ophthalmological and radiological assessments of safety and efficacy
|CNS Neuroscience & Therapeutics|2017|123
Recent advances in using liposomes for delivery of nucleic acid-based therapeutics
|OpenNano|2023|103
Normal outcome of pregnancy in chronic myeloid leukemia treated with interferon‐α in 1<sup>st</sup>trimester: Report of 3 cases and review of the literature
|American Journal of Hematology|2002|82